Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.

There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...

Researchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of developing Alzheimer’s disease. Their ...

Share on Pinterest Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with HIV who are undergoing antiretroviral therapy. Francis ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

Scientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter have received $15.7 million in four separate federal grants to help with their research over ...

Drug-related problems in HIV treatment are prevalent, affecting treatment effectiveness and safety, with 99.7% of patients experiencing at least one DRP. Treatment safety was the most frequent problem ...